Patents by Inventor Brady J. Granier

Brady J. Granier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF PAIN AND NEUROLOGICAL CONDITIONS
    Publication number: 20240009178
    Abstract: The present disclosure is directed toward uses of compound 1 (or its stereoisomers) and compositions and/or dosage forms containing compound 1: or a pharmaceutically acceptable salt thereof. Some uses of Compound 1 and/or its stereoisomers include treating a variety of diseases and disorders, including pain, depression, and schizophrenia. In some embodiments, Compound 1 and/or its stereoisomers may be useful in the treatment of a substance use disorder while inducing fewer withdrawal symptoms than a standard-of-care opioid addiction treatment.
    Type: Application
    Filed: September 21, 2023
    Publication date: January 11, 2024
    Inventors: Brady J. Granier, Jeffrey M. Witkin
  • Treatment of pain and neurological conditions
    Patent number: 11793801
    Abstract: The present disclosure is directed toward uses of compound 1 (or its stereoisomers) and compositions and/or dosage forms containing compound 1: or a pharmaceutically acceptable salt thereof. Some uses of Compound 1 and/or its stereoisomers include treating a variety of diseases and disorders, including pain, depression, and schizophrenia. In some embodiments, Compound 1 and/or its stereoisomers may be useful in the treatment of a substance use disorder while inducing fewer withdrawal symptoms than a standard-of-care opioid addiction treatment.
    Type: Grant
    Filed: February 9, 2022
    Date of Patent: October 24, 2023
    Assignee: BIOCORRX PHARMACEUTICALS, INC.
    Inventors: Brady J. Granier, Jeffrey M. Witkin
  • TREATMENT OF NEUROLOGICAL DISORDERS
    Publication number: 20230310406
    Abstract: The present disclosure is directed toward uses of compound 1 (or its stereoisomers) and compositions and/or dosage forms containing compound 1, wherein compound 1 is N-[2,5-dimethyl-1-(2-phenylethyl)piperidin-4-yl]-N-phenylpropanamide.
    Type: Application
    Filed: June 1, 2023
    Publication date: October 5, 2023
    Inventors: Brady J. Granier, Jeffrey M. Witkin, David Martirosyan
  • Biodegradable Implant Including Naltrexone
    Publication number: 20230097377
    Abstract: A formulation of naltrexone that ameliorates undesirable localized reactions at the site of implantation.
    Type: Application
    Filed: April 1, 2022
    Publication date: March 30, 2023
    Inventors: Brady J. Granier, Ashok Kumar, Vitalii E Stelmakh, Robert P Giannini, JR., Andrew Peter Mallon, George Edward Sherman, JR.
  • TREATMENT OF PAIN AND NEUROLOGICAL CONDITIONS
    Publication number: 20220265627
    Abstract: The present disclosure is directed toward uses of compound 1 (or its stereoisomers) and compositions and/or dosage forms containing compound 1: or a pharmaceutically acceptable salt thereof. Some uses of Compound 1 and/or its stereoisomers include treating a variety of diseases and disorders, including pain, depression, and schizophrenia. In some embodiments, Compound 1 and/or its stereoisomers may be useful in the treatment of a substance use disorder while inducing fewer withdrawal symptoms than a standard-of-care opioid addiction treatment.
    Type: Application
    Filed: February 9, 2022
    Publication date: August 25, 2022
    Inventors: Brady J. Granier, Jeffrey M. Witkin